LYNX1 CAPITAL MANAGEMENT LP CymaBay Therapeutics, Inc. Transaction History

LYNX1 CAPITAL MANAGEMENT LP portfolio value:

$8.14M
portfolio value

LYNX1 CAPITAL MANAGEMENT LP quarter portfolio value change:

+18.64%
quarter

CymaBay Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -10.19% -263.84K shares 500K $3.5 2.32M
Q2 2022 share Increase +86.51% 1.20M shares 3.32M $2.95 2.58M
Q1 2022 share Increase +13.35% 163.53K shares 178K $3.11 1.38M
Q4 2021 share Increase 0.00% 1.22M shares 4.14M $3.3 1.22M